Table 1.
Phosphorylation sites of quantified phosphopeptides that increased in abundance in response to the cAMP-generating hormone mixture (n = 3)
| Gene symbol | Phosphorylation site(s) | log2(H/V) (mean ± SE) |
| Ppp1r1b (DARPP32) | Thr34 | 6.20 ± 0.49 |
| Slc12a1 (NKCC2) | Ser126 | 5.90 ± 0.24 |
| Rap1ga1 | Ser505 | 5.36 ± 0.67 |
| Rap1ga1 | Ser557,Ser574 | 4.98 ± 0.66 |
| Fam54b | Ser38 | 4.83 ± 0.60 |
| Sec22b | Ser137 | 4.74 ± 0.77 |
| Smpx | Ser36 | 4.47 ± 0.42 |
| Smpx | Thr40 | 4.47 ± 0.42 |
| Card14 | Thr278* | 4.47 ± 0.42 |
| Lrba | Ser898 | 4.45 ± 0.17 |
| Sort1 | Ser791 | 3.87 ± 0.46 |
| St14 | Ser13 | 3.73 ± 0.86 |
| Snx3 | Ser72 | 3.47 ± 0.34 |
| Cgnl1 | Thr258, Ser261 | 3.19 ± 0.74 |
| Slc12a1 (NKCC2) | Ser874 | 3.05 ± 0.71 |
| Eplin | Ser132 | 2.88 ± 0.51 |
| Cgnl1 | Ser256, Ser261 | 2.87 ± 0.56 |
| Ank3 | Thr2465 | 2.64 ± 0.45 |
| Kif26a | Ser942 | 2.42 ± 0.53 |
| Rap1ga1 | Ser589 | 2.40 ± 0.30 |
| Ctnnb1 (β-catenin) | Ser552† | 2.15 ± 0.15 |
| Ppp2r5d | Ser632 | 2.11 ± 0.46 |
| Rbm14 | Ser618 | 2.10 ± 0.24 |
| Slc9a3 (NHE3) | Ser552 | 2.07 ± 0.30 |
| Ctnnb1 (β-catenin) | Ser552† | 2.04 ± 0.46 |
| Ctnnb1 (β-catenin) | Thr551* | 2.04 ± 0.46 |
| Aqp2 | Ser256† | 1.70 ± 0.24 |
| Plxdc2 | Ser507 | 1.69 ± 0.32 |
| Aqp2 | Ser256† | 1.60 ± 0.17 |
| Ppp1r1a | Thr35 | 1.53 ± 0.20 |
| Pum1 | Ser710 | 1.52 ± 0.13 |
| Ndrg2 | Thr316* | 1.52 ± 0.30 |
| Plekha6 | Ser1094 | 1.45 ± 0.17 |
| Cyba | Ser168 | 1.34 ± 0.26 |
| Mme | Ser4 | 1.31 ± 0.17 |
| Slc12a1 (NKCC2) | Thr96 | 1.31 ± 0.23 |
| Phldb2 | Ser510 | 1.22 ± 0.17 |
| Fam82a2 | Ser44 | 1.18 ± 0.06 |
| Tns (tensin) | Ser628 | 1.17 ± 0.25 |
| Pxn (paxillin) | Ser315 | 1.00 ± 0.19 |
| Slc2a4 (Glut4) | Ser488* | 0.97 ± 0.22 |
| Slc43a2 (Lat4) | Ser274 | 0.88 ± 0.18 |
| Ank3 | Ser1458 | 0.88 ± 0.20 |
| Golgb1 | Ser614 | 0.64 ± 0.05 |
| Gng12 | Ser49 | 0.63 ± 0.14 |
H, hormone treated; V, vehicle.
*Ambiguous phosphorylation site assignment.
†Site quantified in multiple phosphopeptides.